Erste Asset Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
FCM
AIM
AVM
NAMA
Erste Asset Management's BEAM Position: Q2 2026 in Review
Erste Asset Management opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 41,000 shares worth $1.43M. The stake represents 0.01% of the portfolio and ranks #420 among its holdings. This is a return to the name: Erste Asset Management previously reported a position in BEAM as recently as Q4 2025.
Erste Asset Management first reported a position in BEAM in Q4 2020 and has held it in 22 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.
- Erste Asset Management held 41,000 shares of Beam Therapeutics worth $1.43M as of Q2 2026.
- Beam Therapeutics was a new Erste Asset Management position in Q2 2026.
- Beam Therapeutics made up 0.01% of Erste Asset Management's portfolio in Q2 2026, its #420 holding.
- Erste Asset Management first reported a position in Beam Therapeutics in Q4 2020 and has held it in 22 quarters since.
- 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.
Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.